Neurofibromatosis type 1 is one ofthe most common inherited disorders with an incidence of 1 in 3000. The search for NFI mutations has been hampered by the overall size of the gene, the large number of exons, and the high mutation rate. To date, fewer than 90 mutations have been reported to the NFI mutation analysis consortium and the details on 76 mutations have been published.
terations in exon 27a and the one in exon 45 are predicted to produce a truncated protein. (JMed Genet 1995; 32:706-710) Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders with a birth frequency of approximately 1 in 3000. The disease is characterised by cafe au lait spots, neurofibromas, and Lisch nodules (hamartomas of the iris). NF 1 has many complications which include complex neurocognitive difficulties, plexiform neurofibromas, and an increased risk of specific types of malignancy.'
The NF1 gene is more than 300 kb in size, consists of 59 exons, and has been mapped to 17qll.2.2-5 The NFI transcript encodes a protein, neurofibromin, which is related to a number of GTPase activating proteins (GAP) and is involved in the negative control of ras mediated signal transduction. 6 Neurofibromin also appears to be associated with cytoplasmic microtubules. This association between ras mediated signal transduction and the cytoskeleton suggests that neurofibromin may play multiple roles in the regulation of cell division. 7 The NF 1 mutation rate, approximately 1 x 10-4/gamete/generation,' is the highest de- scribed for any human disorder, and is some 100 fold higher than that usually found at a single locus, with the result that almost half of all cases of NF I represent new mutations. This high mutation rate could either be because of the large size of the NFl gene or the presence of highly mutable sequences within the gene.
The identification and characterisation of disease specific mutations in the NFl gene should enable one to detect such mutational "hot spots" for mutations and to study correlation between the genotype and phenotype. The search for NF1 mutations has been hampered by the overall size of the gene and the large number of exons. To date fewer than 90 mutations have been reported to the NF1 mutation analysis consortium,9 and details of only 76 of these mutations have been published.'0 We have previously reported the identification of 14 20 Direct nucleotide sequencing was carried out on purified PCR product (Gene clean), using the dideoxy chain termination method (Sequenase version 2-0 USB). Sequenase reactions were analysed on a 6% non-denaturing sequence gel, vacuum dried onto filter paper, and then exposed for 24 to 48 hours to x ray film (Fuji) at room temperature.
Results
From a panel of 300 patients studied, five new mutations were identified and were fully characterised by direct sequencing. Of the five nucleotide alterations, four were identified by SSCP (fig 1) . In addition, three de novo intragenic deletions were detected in three of the 11 sporadic cases. The details of each of these mutations are summarised in the table.
In patient NF59, the deletion of an adenine (A), at nucleotide 4630 in exon 27a, generated a shift in the reading frame, resulting in the alteration of eight amino acids before the introduction of an inappropriate stop codon at nucleotide 4655 (fig 2A,B An alteration involving a base pair was identified within exon 45 in patient NF9; this involves a transition from C -+T at position 7846 ( fig 3A) . This change occurs at a CpG dinucleotide and results in the conversion of an arginine to a stop at codon 2612. This woman has typical major defining features with a large plexiform neurofibroma and she represents a new mutation.
In patient NF41, a transition involving a change from A-+G at nucleotide position 7828, which produces an amino acid substitution from threonine to alanine, was found ( fig 3B) . nucleotide This alteration was not detected in any of eletion the 70 normal controls or in 199 other NFI which patients. This mutational change also creates a new restriction site for the enzyme AciI within a normally generated 269 bp fragment, which as a result is cleaved into two fragments of 117bp and 152 bp, and the presence of this restriction site segregates with the disease. This is a non-conservative change and results in the substitution of a non-polar for a polar amino acid.
Only one new mutational change was identified by heteroduplex analysis on MDE gels. This was an A-+G transition at nucleotide 11 715 in exon 49, within the 3' UTR. This patient, NF130, has mild cutaneous involvement and no complications. She is the first case in her family. She has had three affected children from separate marriages and two of these children have NFI and learning difficulties, but the samples from these were not available for analysis.
Eleven sporadic NF1 patients, where DNA was available from normal parents, were screened with two new microsatellite markers from within introns 27 and 38. In three of these families, the affected subjects were found to be hemizygous at these CA repeats owing to the presence of interstitial deletions involving intron 27 to intron 38 of the NF1 gene in one case and only intron 38 in the other two NFI patients (fig 4) . In all three families, the origin of new mutation was in the maternal germlines. To define the extent of these three deletions, cytosine to the families were further analysed by screening ent NF41 with the exon 5 polymorphism.'9 Unfortunately all the affected subjects were homozygous for this polymorphism; however, with the intron 41 polymorphism,20 the NFl patient from two families had not inherited the maternal allele. To date, a total of 16 nucleotide substitutions have been reported in the NF1 gene.'025-293' Indeed, eight of the 16 nucleotide substitutions so far reported in over 600 patients screened involve a C -+T change at a CpG dinucleotide. The change in patient NF9 in the present study also involves a CpG dinucleotide. There is now clear evidence that the presence of CpG dinucleotides are associated with a high mutation rate, as it has been shown that alterations at these dinucleotides account for at least 35% of all point mutations causing genetic disorders. 32 In patient NF130, the A-+G change at nucleotide position 11 715 is within the 3' UTR distal to exon 49 and is the only change so far reported in this region. She has three affected children from separate marriages and two of these children have NF1 and learning difficulties. It has been reported that the 3' UTR of the human NF1 gene is highly conserved in the mouse,33 and therefore mutations within this region may be important for mRNA stability or translational efficiency.
Mutations have been found to occur nonrandomly with respect to the surrounding DNA sequence in human genes.3234 Certain sequences in the human genome are associated with the preferential formation of insertions and deletions. These sequence patterns include direct repeats, palindromes, quasi-palindromes, and runs of identical bases. This is consistent with a mutational mechanism based on the slipped mispairing model which suggests that misalignment can occur between such dir-ect repeats during replication. 
